» Authors » Martinus T van de Bilt

Martinus T van de Bilt

Explore the profile of Martinus T van de Bilt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 60
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Serpa M, Doshi J, Joaquim H, Vieira E, Erus G, Chaim-Avancini T, et al.
Schizophr Res . 2023 May; 257:5-18. PMID: 37230043
Objectives: Schizophrenia-related psychosis is associated with abnormalities in white matter (WM) microstructure and structural brain dysconnectivity. However, the pathological process underlying such changes is unknown. We sought to investigate the...
2.
Diniz G, Santos P, Andrade J, Alves T, Hortencio L, van de Bilt M, et al.
Braz J Psychiatry . 2021 Nov; 43(5):560-562. PMID: 34730718
No abstract available.
3.
Pereira C, Costa A, Joaquim H, Talib L, van de Bilt M, Loch A, et al.
World J Biol Psychiatry . 2021 Sep; 23(3):236-241. PMID: 34547958
Background: The identification of Ultra-High Risk (UHR) individuals is thought to be useful for early intervention to improve psychosis outcomes. However, transition rates vary widely, and there is an effort...
4.
Talib L, Costa A, Joaquim H, Pereira C, van de Bilt M, Loch A, et al.
Eur Arch Psychiatry Clin Neurosci . 2021 Mar; 271(8):1593-1599. PMID: 33677687
Phospholipase A is the main enzyme in the metabolism of membrane phospholipids. It comprises a family of enzymes divided into iPLA, cPLA and sPLA. Studies have reported increased PLA activity...
5.
Gattaz W, Saracco-Alvarez R, Daltio C, van de Bilt M, Ortegon J, Villasenor-Bayardo S, et al.
Neuropsychiatr Dis Treat . 2020 Sep; 16:2063-2072. PMID: 32982245
Background: Paliperidone palmitate is a long-acting, second-generation antipsychotic (SGA) indicated for the treatment of acute exacerbations and maintenance treatment of adults with schizophrenia. This study addressed the response to paliperidone...
6.
Nogueira A, Andrade J, Serpa M, Alves T, Freitas E, Hortencio L, et al.
Braz J Psychiatry . 2020 Aug; 43(3):285-288. PMID: 32756811
Objective: To assess the influence of migration on the psychopathological presentation of individuals at ultra-high risk for psychosis (UHR) in São Paulo, Brazil. Methods: This study is part of the...
7.
Joaquim H, Zanetti M, Serpa M, van de Bilt M, Sallet P, Chaim T, et al.
Schizophr Res . 2017 Sep; 195:402-405. PMID: 28888361
Past studies have linked intracellular pathways related to psychotic disorders to the GSK3B enzyme. This study aimed to investigate GSK3B protein expression and phosphorylation in drug-naïve first-episode psychosis patients (n=43)...
8.
Loch A, van de Bilt M, Bio D, Prado C, Sousa R, Valiengo L, et al.
Braz J Psychiatry . 2015 Sep; 37(3):235-41. PMID: 26376054
Objective: To assess the relationship between cognitive function, a proposed schizophrenia endophenotype, and two genetic polymorphisms related to dopamine function, catechol-O-methyl transferase (COMT) Val158Met and dopamine receptor 3 (DRD3) Ser9Gly....
9.
Sousa R, Busnello J, Forlenza O, Zanetti M, Soeiro-de-Souza M, van de Bilt M, et al.
J Psychiatr Res . 2012 Sep; 46(12):1564-8. PMID: 23000368
Although lithium has been the first line agent in the treatment of bipolar disorder (BD), few studies have evaluated lithium's efficacy in mania with psychosis and its association with later...
10.
Sousa R, van de Bilt M, Diniz B, Ladeira R, Portela L, Souza D, et al.
Neurosci Lett . 2011 Mar; 494(1):54-6. PMID: 21362460
Several studies have suggested an important role for brain-derived neurotrophic factor (BDNF) in the pathophysiology and therapeutics of bipolar disorder (BPD). The mechanisms underlying the therapeutic effects of lithium in...